Skip to main content

Cardiology Update London 2023

London, UK
Type of event
on site


Dear Colleagues

It is a real pleasure to welcome you the 7th Christmas Postgraduate Course of the Royal Brompton and Harefield NHS Foundation Trust & Imperial College, the Cardiology Update London.

Cardiology and cardiovascular medicine in general is a rapidly expanding field with impressive developments and innovations over the last years. For physicians, be it general practitioners, cardiologists or cardiac surgeons, it is therefore important to keep pace with a challenging environment. To that end, we have designed a postgraduate course, the Cardiology Update London, to summarize, at the end of the year, the most important new developments, innovations, but also failures that will all affect cardiovascular diagnosis and management in our everyday practice.

We have selected an international Faculty of high standing experts both from the Trust and worldwide, covering the broad spectrum of cardiovascular medicine from prevention to intervention, from valvular heart disease to heart failure, and from conservative management to intervention and surgical operations. Thus, the course will give an up-to-date overview about current diagnosis and management of the most important cardiovascular conditions during two days in London.

We would be most happy to welcome you at the Royal Society of Medicine in central London to enjoy two days of interactive education for the benefit of your practice and your patients.

Prof. Thomas F. Lüscher

Dr. Peter Libby

Prof. Bernard J. Gersh   

Dr. Richard Grocott-Mason

Dr. Ruth Amstein


Programme Overview

Programme Overview

Monday , December 11th (UK Time)Tuesday, December 12th (UK Time)

Welcome Address
Opening Lectures

  • Frontiers in cardiovascular science

Session 4
Arrhythmias and Sudden Cardiac Death

  • Atrial fibrillation
  • Cardiogenic shock and effect of assist devices (Impella)
  • Personalised indication for ICD

Session 1
Risk Factors and Prevention

  • Dyslipidaemias
  • siRNA therapeutics
  • 2023 ESC Diabetes Guidelines
  • Obesity
  • Vaccination

Session 5
Valvular Heart Disease

  • Aortic, mitral and tricuspid valve disease
  • Multiple heart valve disease
12:30Satellite Symposium12:30Satellite Symposium
13:15Lunch Break13:15Lunch Break

Session 2
Acute and Chronic Coronary Syndromes

  • Intracoronary Imaging
  • ESC 2023 ACS Guidelines
  • Challenges in PCI
  • From plaque rupture to erosion
  • PCI for ischemic cardiomyopathy








The Paul Hamilton Wood Lecture

Session 6
Heart Failure: Established and Novel Drugs/Advanced Stage

  • Update of ESC Guidelines
  • Management of HFpEF
  • Iron deficiency in HF
16:45Satellite Symposium  

Session 3
Practical Implications of the new ESC Guidelines

  • Cardiomyopathies
  • Endocarditis

Session 7
Heart, Kidney and Cardiomyopathies

  • The cardiorenal axis
  • HF and CKD
  • Update in Cardio-oncology
18:15Networking Reception17:30Adjourn



Monday, December 11th, 2023 (UK time)

Venue: The Royal Society of Medicine

08:30-09:00 | Welcome Address 
08:30Welcome by the ESC President:
The future of Cardiology in Europe
Thomas F. Lüscher, London


08:45 - 09:45 | Opening Lectures: Frontiers in Cardiovascular Science
Chair: Thomas F. Lüscher, London and Filippo Crea, Rome
08:45Opening Lectures 1:
From managing to cure: Genetic therapy for cardiomyopathies
Hugh Watkins, Oxford
09:15Opening Lecture 2:
Lipoprotein (a) a risk factor for CAD and aortic stenosis?
Børge G. Nordestgaard,   Copenhagen
09:45- 10:15 COFFEE BREAK 


10:15 - 12:30 | Session 1: Risk Factors and Prevention
Chairs: Mahmoud Barbier, Harefield and John E. Deanfield, London
10:15Development of nucleic-acid based therapies to
lower atherogenic lipoproteins
Ulf Landmesser, Berlin
10:35Novel antilipidaemic drugs: Novel trials and clinical outcomesAlberico L. Catapano, Milan
10:55The 2023 ESC Guidelines on Cardiovascular Disease and DiabetesNikolaus Marx, Aachen
11:15Obesity: New options for a rising issue in cardiovascular medicineNaveed Sattar, Glasgow
11:35Vaccination as a new form of cardiovascular preventionThomas F. Lüscher, London
11:55Panel DiscussionAll


12:30 - 13:15 | Industry-Sponsored symposium
13:15-14:00 Lunch Buffet


14:00 - 16:15 | Session 2: Acute and Chronic Coronary Syndromes
Chairs: Richard Grocott-Mason, London and Peter Libby, Boston
14:00Intracoronary imaging and clinical outcomes   Lorenz Räber, Bern
14:20ESC 2023 Guidelines on Acute Coronary SyndromesBorja Ibáñez, Madrid
14:40Challenges in PCI: high-risk and complex lesions (CHIP)Jonathan Hill, London
15:00Patient case TBD (interactive voting)Mohammed Majid Akhtar, London
15:20From plaque rupture to erosion: A step towards precision medicine?Filippo Crea, Rome
15:40PCI for ischemic cardiomyopathy: The Revived TrialDivaka Perera, London
16:00Panel Discussion 
16:15- 16:45 COFFEE BREAK 


16:45 - 17:15 | Industry-Sponsored Symposium


17:15 - 18:45 | Session 3: Practical Implications of the new ESC 2023 Guidelines
Chairs: Divaka Perera, London and Eleanor Wicks, Oxford
17:15CardiomyopathiesJuan Pablo Kaski, London
17:40EndocarditisVictoria Delgado, Badalona
18:15    Cross-functional Networking Reception

Tuesday, December 12th, 2023 (UK Time)

Venue: The Royal Society of Medicine

08:30 - 10:30 | Session 4: Arrhythmias, Sudden Cardiac Death
Chairs: Vias Markides, London and Tom Wong, London
08:30Pulse field ablation of atrial fibrillation: A revolution?   Gerhard Hindricks, Berlin
08:50Upstream therapy for the prevention of AF: Is it realistic?Bernard Gersh, Rochester
09:10My patient with AF and ischemic heart disease (interactive voting)Shouvik Haldar, London
09:30Cardiogenic shock and effect of assist devicesSusanna Price, London
09:50Personalized indication for ICD? Genetics, fibrosis and LVEFLars Køber, Copenhagen
10:10Panel discussionAll
10:30-11:00COFFEE BREAK 


11:00- 12:45 | Session 5: Valvular Heart Disease
Chairs: Miles Dalby, London and Simon Davies, London
11:00Multimodality imaging in transcatheter aortic valve replacementAlison Duncan, London
11:20TAVI versus SAVR: moving indications?Stephan Windecker, Berne
11:40Secondary mitral regurgitation: Medication, TEER or surgery?Francesco Maisano, Milano
12:00TEER for tricuspid regurgitation: ILLUMINATE and beyondGeorg Nickenig, Bonn
12:20Panel discussion 


12:30 - 13:15 | Industry-Sponsored Symposium
13:15-14:00    Lunch Buffet


14:00 - 14:30 | The Paul Hamilton Wood Lecture
Chairs: Thomas F. Lüscher, London Bernard Gersh, Rochester
14:00Is targeting inflammation ready for prime time?Peter Libby, Boston


14:30 - 15:45 | Session 6: Heart Failure: Established and Novel Drugs / Advanced Stage
Chairs: Owais Dar, Harefield and Bernard Gersh, Rochester
14:30Focused update on the 2021 ESC HF GuidelinesMarco Metra, Brescia
14:50HFpEF: From hemodynamics to managementBarry Borlaug, Rochester
15:10Iron deficiency in heart failure   Paul Kalra, Portsmouth
15:30Panel discussion 
15:45 - 16:15 COFFEE BREAK 


16:15 - 17:30 | Session 7: Heart, Kidney and Cardiomyopathies
Chairs: Paul Kalra, Portsmouth and Alexander Lyon, London
16:15Is LVEF still important for HF management?Pardeep Jhund, Glasgow
16:35The cardiorenal axis: new treatment targetsChristoph Wanner, Wuerzburg
16:55Cardio-oncology - a rapidly evolving fieldSohaib Nazir, London
17:15Panel discussion 
17:30Wrap-up and AdjournThomas F. Lüscher, London


Satellite Symposia


Teaching Faculty

Mohammed Majid Akhtar
London, UK

Mahmoud Barbir
Harefield, UK

Barry A. Borlaug
Rochester MN, USA

Alberico L. Catapano
Milan, IT

Filippo Crea
Rome, IT

Miles Dalby
Harefield, UK

Simon Davies
London, UK

Owais Dar
Harefield, UK

John E. Deanfield
London, UK

Victoria Delgado
Badalona, ES

Alison Duncan
London, UK

Bernard J. Gersh
Rochester MN, USA

Richard Grocott-Mason
London, UK

Shouvik Haldar
London, UK

Jonathan Hill
London, UK

Gerhard Hindricks
Berlin, DE

Borja Ibáñez Cabeza
Madrid, ES

Pardeep Jhund
Glasgow, UK

Paul Kalra
Portsmouth, UK

Juan Kaski
London, UK

Lars Køber
Copenhagen, DK

Ulf Landmesser
Berlin, DE

Peter Libby
Boston, USA

Thomas F. Lüscher
London, UK

Alexander Lyon
London, UK

Francesco Maisano
Milan, IT

Vias Markides
London, UK

Nikolaus Marx
Aachen, DE

Marco Metra
Brescia, IT

Sohaib Nazir
London, UK

Georg Nickenig
Bonn, DE

Børge Nordestgaard
Herlev, DK

Divaka Perera
London, UK

Susanna Price
London, UK

Lorenz Räber
Berne, CH

Naveed Sattar
Glasgow, UK

Christoph Wanner
Wuerzburg, DE

Hugh Watkins
Oxford, UK

Stephan Windecker
Berne, CH

Eleanor Wicks
Oxford, UK

Tom Wong
London, UK




Registration fees 
Regular feeGBP 300
Early registration fee (until November 10, 2023)GBP 250
Trainees/Residents, Research fellows, Nurses, Students <40 years (ID proof required)* 
Regular feeGBP 150
Early registration fee (until November 10, 2023)GBP 100
Day TicketGBP 150
Group Registration (For group registrations a minimum of 10 participants is required)** 
Regular feeGBP 260
Early registration fee (until November 10, 2023)GBP 210

*For the reduced registration (Trainees/Residents, Research fellows, Nurses, Students <40 years) please send a copy of your ID to Ms. Nadine-Estelle Abea at

**Please contact Ms. Nadine-Estelle Kaltheuner ( at the Zurich Heart House to obtain further information.

Registration will be confirmed upon receipt of payment.
Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.

Modification & Cancellation

All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to the Zurich Heart House. For each modification requested by the participant, GBP 50 will be charged for administrative costs. In case of cancel-lation up to 1st of November 2023, deposits will be refunded less 35 % for administrative costs. After this date, no refund will be possible.


The Royal Society of Medicine,
1 Wimpole St, Marylebone, London W1G 0AE, United Kingdom


Zurich Heart House, Foundation for Cardiovascular Research
Dr. Ruth Amstein
Nadine-Estelle Abea
Hottingerstrasse 14, CH-8032 Zurich, Switzerland
Phone +41 (0) 44 250 40 95, Fax +41 (0) 44 250 40 90




The Cardiology Update London is recognised by the following institutions as accredited continuing education:

-Federation of the Royal Colleges of Physicians of the
United Kingdom for CPD credits
13 category 1 (external) CPD credits

European Accreditation Council for Continuing
Medical Education (EACCME®)
12 European CME credits (ECMEC®s)



Organized by

In collaboration with